Stocks to Watch: PepGen, Phreesia, Virgin Galactic
Dow Jones03-31
By Katherine Hamilton
PepGen reported mixed results for its trial of a muscle-disorder treatment. Shares fell 42% to $2.44 in after-hours trading Monday.
Phreesia cut its fiscal year 2027 revenue guidance. The stock slid 23% to $8.80 after the bell.
Virgin Galactic narrowed its loss in the fourth quarter. Shares rose 9% to $2.37.
Write to Katherine Hamilton at katherine.hamilton@wsj.com
(END) Dow Jones Newswires
March 30, 2026 19:05 ET (23:05 GMT)
Copyright (c) 2026 Dow Jones & Company, Inc.
At the request of the copyright holder, you need to log in to view this content
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments